Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Financial Ratios
Transgene Biotek Ltd.
BSE Code 526139
ISIN Demat INE773D01018
Book Value (Rs) -0.89
NSE Code NA
Dividend Yield % 0.00
Market Cap(Rs Mn) 484.93
TTM PE(x) 0.00
TTM EPS(Rs) -0.03
Face Value (Rs) 10  
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operational & Financial Ratios          
   Earnings Per Share (Rs)-0.09  -0.79  -1.37  -1.38  -1.45  
   CEPS(Rs)-0.07  -0.14  -0.06  -0.07  -0.14  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)-0.91  -0.82  -0.03  0.62  1.99  
   Tax Rate(%)0.00  0.00  0.00  0.00  0.00  
Margin Ratios          
   Core EBITDA Margin(%)-258.11  -1104.17  -531.84  -307.22  0.00  
   EBIT Margin(%)-219.63  -9769.69  0.00  -5993.54  0.00  
   Pre Tax Margin(%)-279.05  0.00  0.00  -6153.44  0.00  
   PAT Margin (%)-279.05  0.00  0.00  -6153.44  0.00  
   Cash Profit Margin (%)-239.76  -1917.60  -550.95  -309.70  0.00  
Performance Ratios          
   ROA(%)-2.02  -17.24  -24.70  -20.09  -17.75  
   ROE(%)0.00  0.00  -465.75  -105.59  -53.27  
   ROCE(%)-7.35  -57.47  -73.15  -49.07  -34.91  
   Asset Turnover(x)0.01  0.00  0.00  0.00  0.00  
   Sales/Fixed Asset(x)0.00  0.00  0.00  0.00  0.00  
   Working Capital/Sales(x)-0.02  -0.01  -0.01  -0.01  0.00  
Efficiency Ratios          
   Fixed Capital/Sales(x)458.09  1952.92  1241.19  634.57  0.00  
   Receivable days0.00  0.00  0.00  0.00  0.00  
   Inventory Days52.60  425.35  242.36  63.44  3548.64  
   Payable days0.00  1187.70  -1746.92  1857.70  8270.20  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  0.00  
   PCE(x)-109.51  -17.86  -57.27  -66.09  -21.41  
   Price/Book(x)-8.98  -3.04  -138.83  7.44  1.51  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)322.14  580.46  453.93  271.42  9256.18  
   EV/Core EBITDA(x)-178.64  -73.86  -158.33  -181.18  -48.35  
   EV/EBIT(x)-146.68  -5.94  -3.87  -4.53  -3.13  
   EV/CE(x)10.61  4.63  1.06  0.98  0.58  
   M Cap / Sales262.57  342.41  315.51  204.68  6378.80  
Growth Ratio          
   Net Sales Growth(%)326.32  -36.44  -48.87  4642.12  -94.98  
   Core EBITDA Growth(%)2.17  -74.21  2.14  62.89  -150.16  
   EBIT Growth(%)90.42  47.08  -0.11  3.96  -24.05  
   PAT Growth(%)89.09  42.25  0.30  4.83  -24.67  
   EPS Growth(%)89.09  42.25  0.30  4.83  -24.67  
Financial Stability Ratios          
   Total Debt/Equity(x)-2.04  -2.11  -60.99  2.43  0.68  
   Current Ratio(x)0.10  0.10  0.08  0.05  0.05  
   Quick Ratio(x)0.10  0.10  0.07  0.04  0.05  
   Interest Cover(x)-3.70  -8.63  -44.40  -37.48  -27.78  
   Total Debt/Mcap(x)0.23  0.70  0.44  0.33  0.45